Heteroaryl compounds as protein kinase inhibitors

Provided herein are compounds of formula (I), R1, R2, R3, A, Q, Z, X, and W as described in the specification, as well as solvates, hydrates, tautomers, or pharmaceutically acceptable salts thereof, which have activity on receptor protein tyrosine kinases. 本文提供了对受体蛋白酪氨酸激酶具有活性的式(I)化合物，R1、R2、R3、A、Q、Z、...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	LI JUNQING, KANG XINSHAN, LIAN XIN, FU YUELI, ZHENG JIANJIA, GONG XUAN, WANG RUYONG, FENG YAN
Format:	Patent
Sprache:	chi ; eng
Schlagworte:	ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Provided herein are compounds of formula (I), R1, R2, R3, A, Q, Z, X, and W as described in the specification, as well as solvates, hydrates, tautomers, or pharmaceutically acceptable salts thereof, which have activity on receptor protein tyrosine kinases. 本文提供了对受体蛋白酪氨酸激酶具有活性的式(I)化合物，R1、R2、R3、A、Q、Z、X和W在本说明书中描述，以及其溶剂合物，水合物，互变异构体或其药学上可接受的盐。